title: Review: Immune-Related Adverse Events With Use of Checkpoint Inhibitors for Immunotherapy of Cancer.
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston.
authors.forename: Maria E
authors.initials: ME
authors.lastname: Suarez-Almazor
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston.
authors.forename: Sang T
authors.initials: ST
authors.lastname: Kim
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, and Assiut University Hospitals, Assiut, Egypt.
authors.forename: Noha
authors.initials: N
authors.lastname: Abdel-Wahab
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston.
authors.forename: Adi
authors.initials: A
authors.lastname: Diab
mesh_terms: D000074322:Antineoplastic Agents, Immunological / Q000009:adverse effects* / Q000627:therapeutic use; D060908:CTLA-4 Antigen / Q000037:antagonists & inhibitors*; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects*; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology
chemical_list: D000074322:Antineoplastic Agents, Immunological; D060908:CTLA-4 Antigen